The effects of intravenous infusion of arginine (20 g/m2) after an overnight fast on plasma immunoreactive growth hormone (GH), insulin (IRI), and glucagon (IRG), and blood glucose were examined in five groups of children and adolescents: 10 normal individuals, 18 with idiopathic short stature, 6 with isolated growth hormone deficiency, 8 with panhypopituitarism, and 6 with anorexia nervosa.
to the value for the normal group in all other groups. After arginine infusion, four-to sixfold increases of plasma G H were observed in the normal children, and similar increases were seen in those with idiopathic short stature as well as in those with anorexia nervosa; whereas, in the children with isolated growth hormone deficiency or panhypopituitarism, there was no significant increase in plasma GH. Fasting blood glucose concentrations were significantly lower than normal in subjects with isolated growth hormone deficiency ( P < 0.05), panhypopituitarism ( P < 0.001), and anorexia nervosa (P < 0.001), whereas fasting plasma IRI and IRG concentrations were similar to the values in the normal group. Plasma IRI increased eightfold at the end of the 30-min arginine infusion in the normal subjects; the increase was slightly but not significantly less in those with idiopathic short stature, and significantly less in those with isolated growth hormone deficiency ( P < 0.05), panhypopituitarism ( P < 0.001), and anorexia nervosa ( P < 0.05). Arginine infusion resulted in two-to threefold increases of plasma IRG in the normal group, and similar increases were observed in all of the other groups tested. These results suggest that whereas pancreatic P cell responsiveness may be deficient in children and adolescents with isolated growth hormone deficiency, panhypopituitarism, or anorexia nervosa, pancreatic a cell responsiveness, to arginine a t least, appears to be intact under these conditions.
Speculation
Although plasma glucagon responses to arginine infusion were not less in subjects with hypopituitarism or anorexia nervosa than in normal subjects, relative hypoglucagonemia may have existed, since both basal and postarginine infusion plasma glucagon levels were not higher than normal in the presence of significantly lower blood glucose values. Thus, the present study does not exclude a deficient pancreatic a cell response to hypoglycemia. Alternatively, nonavailability of substrates for gluconeogenesis may have a more important influence than hormonal factors in the genesis of the hypoglycenia observed in these states.
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The relationship between hypopituitarism and hypoglycemia has long been recognized (6) and is the subject of a recent review by Hopwood et al. (26) . Among factors regulating the blood glucose concentration, pancreatic insulin, as well as glucagon (48) , is recognized to have a prominent role. The influence of growth hormone on pancreatic fi cell function is well documented, and insulin responses to provocative stimuli have usually been reported 
' Mean i SE values for number of subjects indicated in parentheses. to be decreased in subjects with growth hormone deficiency (8, 13, 18, 39, 41) . Effects of growth hormone on pancreatic oc cell function have only recently been reported (5, 20) . The aim of the present experiments was to test pancreatic glucagon as well as insulin responsiveness in children and adolescents with deficiency of growth hormone secretion, and in others with idiopathic short stature or anorexia nervosa. Arginine infusion permitted the simultaneous assessment of plasma growth hormone, insulin, and glucagon secretory responses.
MATERIALS AND METHODS

SUBJECTS
The characteristics of the subjects studied are shown in Table 1 . The first group consisted of 10 children and adolescents (4 females and 6 males, ages 6 years 9 months to 15 years) admitted to the surgery ward for minimal orthopedic trauma, but otherwise healthy, and these subjects served as "normal" control subjects. The second group consisted of 18 subjects (2 females and 16 males, ages 5 years 6 months to 15 years 5 months) with short stature (less than normal by 2 or more SD), and in whom no abnormality of pituitary, thyroid, or gonadal function was found. The third group consisted of 6 subjects (1 female and 5 males) with isolated GH deficiency. Plasma GH responses to insulin-induced hypoglycemia were severely blunted; plasma thyroxine levels were normal. Adrenocorticotropic hormone (ACTH) secretion was normal, as assessed indirectly after administration of metyrapone. Responses to synthetic gonadotropin-releasing hormone were normal in the 3 younger children with isolated GH deficiency, and gonadotropic secretion in the 3 older ones was considered normal, since pubertal development had begun. The fourth group consisted of 8 subjects (3 females and 5 males) with panhypopituitarism. All had GH, TSH, and ACTH deficiencies, and gonadotropic deficiency was demonstrated in 2 of the 8 cases. Diabetes insipidus was present in the 4 cases which had a tumoral origin, whereas, in the 4 idiopathic cases, diabetes insipidus was absent. All the patients with panhypopituitarism were receiving dessicated thyroid gland powder and cortisone substitution (25 mg/m2/24 hr). None of the patients had received human growth hormone before or during the time of testing. The fifth group consisted of 6 female adolescents with anorexia nervosa; weight loss was between 35% and 38% below ideal body weight, and amenorrhea was present.
METHODS
All of the studies were performed after informed consent. After 3 days of a diet consisting of 55% carbohydrate, 17% fat, and 28% protein, and after an overnight fast, an intravenous infusion of isotonic saline was established in an antecubital vein. After a 30-min equilibration period, arginine monohydrochloride 20 g/m2 (20 g/100 ml, buffered to pH 7.4) was infused during 30 min (0-30 min). Blood was collected in chilled heparinized plastic tubes containing EDTA and Trasylol at -30, 0, 30, 60, 90, and 120 min. Plasma was stored at -20' until assayed. Blood glucose was estimated by the AutoAnalyzer ferricyanide method (7) . Plasma growth hormone and insulin concentrations were determined by double-antibody radioimmunoassays (24, 30) . Plasma immunoreactive glucagon was assayed (49) using an antipancreatic glucagon antiserum which purportedly measures true pancreatic glucagon (30-K antiserum, kindly provided by Dr. R. H. Unger, University of Texas South-Western Medical School, Dallas, Texas). Table 1 , the mean age of the control population of normal children was around early adolescence; the ratio of mean weight to mean height was approximately at the 50th percentile. The mean age of the children with idiopathic short stature was 10.5 years. The height of this group corresponded to that of normal 7-year-old children, and they were slightly overweight (at 90th percentile for height). The mean age, height, and weight of the groups with idiopathic short stature and panhypopituitarism were very similar. The group with isolated growth hormone deficiency had an adolescent mean age, and was also overweight (90th percentile for height). The group with anorexia nervosa was significantly underweight for height, the latter being comparable with the normal control group.
RESULTS
As indicated in
after the end of the arginine infusion (60 min). The G H response to arginine infusion was similar in children with idiopathic short stature, with a peak value of 14.3 * 2.3 ( P < 0.001) at 60 min. By contrast, in children with isolated growth hormone deficiency and in those with panhypopituitarism, plasma G H levels after arginine infusion did not rise significantly, and the concentrations attained were significantly lower than the values in the normal subjects at corresponding times. The mean fasting preinfusion plasma GH concentration in the group with anorexia nervosa (9.6 * 4.2 ng/ml) was significantly higher ( P < 0.05) than the corresponding mean fasting value for the normal group (2.7 * 0.7 ng!ml), and at 30 min after arginine infusion, plasma G H rose to significantly higher levels ( P < 0.05) in the group with anorexia nervosa (24.1 4.1 ng/ml) than in the normal subjects (15.6 * 3.2 ng/ml). (Table 3) The mean fasting preinfusion blood glucose concentrations were significantly lower in subjects with isolated growth hormone deficiency (73 * 5 mg/100 ml, P < 0.05), panhypopituitarism (60 i 6 mg/100 ml, P < 0.001), and anorexia nervosa (63 i 3 mg/100 ml, P < 0.001), than in normal subjects (83 i 2 mg/100 ml).
BLOOD GLUCOSE
Fasting blood glucose concentrations were not significantly below normal in subjects with idiopathic short stature (83 * 2 mg/100 PLASMA IMMUNOREACTIVE GH ( Table 2) ml). There was a small but nonsignificant increase of blood glucose in the normal subjects at the end of the 30-min arginine infusion
In normal children, plasma G H rose significantly from a mean (from 82 * 2 to-95 i 3 mg/100 ml) followed b; a return to (of -30 and 0 min) rein fusion fasting concentration of 2.7 * 0.7 preinfusion or slightly lower values 30 min after the end of the ng/ml to a peak value of 15.6 i 3.2 nglml ( P < 0.005) at 30 min infusion. Similar changes were seen in all other groups. Data are presented as in Table 2 . Blood glucose concentrations at the times indicated are expressed in milligrams per 100 ml.
P < 0.05 versus mean blood glucose concentration at corresponding times in the normal group. P < 0.001 versus mean blood glucose concentration at corresponding times in the normal group. P < 0.005 versus mean blood glucose concentration at corresponding times in the normal group. 
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CI C N R E S I R T PG
Mean i SE (6) Data are presented as in Table 2 . Plasma insulin concentrations are expressed in microunits per milliliter P < 0.001 versus preinfusion (mean of -30 and 0 min), plasma insulin concentration. P < 0.02 versus preinfusion (mean of -30 and 0 min), plasma insulin concentration. P < 0.05 versus mean plasma insulin concentrations at corresponding times in the normal group. P < 0.001 versus mean plasma insulin concentrations at corresponding times in the normal group. Table 4) DISCUSSION Fasting plasma IRI levels were not significantly different in the various groups. In normal children, plasma IRI rose significantly from a mean preinfusion concentration of 7.1 1.2 pU/ml to 57.6 & 8.7 at the end of a 30-min infusion of arginine ( P < 0.001) and 17.5 + 3.3 at 60 min ( P < 0.02). The IRI responses to the infusion of arginine were lower than normal in children with idiopathic short stature (31.1 + 6.1 pU/ml at 30 min); however, the difference from normal was not significant. By contrast, the increases of plasma IRI after arginine infusion were significantly smaller in the group of children with isolated growth hormone deficiency (23.6 * 9.0 pU/ml at 30 min; P < 0.05), panhypopituitarism (10.5 i 4.5 pU/ml at 30 min, P < 0.001), and anorexia nervosa (24.9 * 9.5 u U l m l at 30 min, P < 0.05).
PLASMA IMMUNOREACTIVE INSULIN (IRI) (
In clinical investigation, the intravenous infusion of arginine has become a useful tool for stimulating growth hormone (l5,42), insulin (12) , and glucagon secretion (3, 48) , and has been widely used for diagnosis of growth hormone deficiency. Similarly, in the present study, plasma G H responses to arginine in children and adolescents with idiopathic short stature were not significantly different from those observed in normal control subjects, but were severely blunted in individuals with either isolated growth hormone deficiency or panhypopituitarism. Thereby, the arginine infusion test has been validated as a diagnostic tool.
In anorexia nervosa, basal plasma G H levels have been reported to be either high (9, 21, 29, 31, 37) or low (14) , and plasma G H levels have been reported to be low in marasmus (4, 16, 17) or in maternal deprivation (45) . On the contrary, they were found to be high in kwashiorkor (4, 16, 17, 36, 44) . In two of our six cases with anorexia nervosa, plasma G H was clearly higher than normal, both in the fasting state, and at 60 and 90 min after arginine infusion.
Both stirnulatory (8, 13, 35, 39, 40, 43, 46, 51) and inhibitory (1)
Fasting plasma IRG levels were not significantly different for the different groups. In normal children, plasma IRG increased significantly from a mean preinfusion concentration of 89 & 23 pg/ml to 231 * 60 pg/ml at the end of the 30-min infusion of arginine (P < 0.005) and 181 4 39 pg/ml at 60 min (P < 0.02).
The plasma IRG response to arginine infusion was not significantly less than normal in the group with idiopathic short stature. In both groups with growth hormone deficiency (isolated G H deficiency and panhypopituitarism) and in the group with anorexia nervosa, plasma IRG responses to arginine were slightly higher than in normal children; however, the differences were not effects of growth hormone on insulin secretion have been reported. In children with growth hormone deficiency, plasma IRI responses to arginine (8, 41, 46, 50, 51) or to glucose (47) have been reported as either normal or decreased. The mean plasma IRI responses to arginine in the groups with isolated growth hormone deficiency and panhypopituitarism were significantly decreased; however, there was a great individual variation, some subjects exhibiting a normal insulin response. The latter was usually associated with a significant. normal basal (preinfusion) plasma insulin level, in turn possibly related to the more normal weight to height ratio in these individuals (26) . An age-dependent response of IRI to different stimuli in hypopituitarism has also been shown (26) ; however, this does not appear to account for the individual differences observed in the present study. It is well recognized that the blood glucose level can modulate the insulin secretory response to different agents, including arginine (10, 19, 34) . Indeed, the poorest plasma I R I responses to arginine were observed in the groups (i.e., anorexia nervosa, panhypopituitarism, and isolated growth hormone deficiency) which has blood glucose concentrations (fasting and postarginine infusion) lower than normal; however, the individual differences do not appear to be explained on this basis. Hypoinsulinemia has also been reported in chronic starvation (I I, 17, 23) and prolonged fasting has been reported to blunt the insulin secretory response to arginine (2) . Similarly, in the present study, the mean plasma IRI response to arginine in the six adolescent females with anorexia nervosa was significantly less than in the normal group. Also, in agreement with several reports (22, 25, 27) , the group of children with idiopathic short stature had decreased plasma IRI levels, both before and after arginine, although the differences from normal were not significant.
A diminished plasma IRG response to arginine in growth hormone deficient adults was first reported by Goldfine et al. (20, 33) . More recently, Blackard et al. (5) found normal plasma IRG responses to arginine in adult subjects with hypopituitarism before and after growth hormone administration. Normal glucagon responses were observed (28) in children with idiopathic short stature. In the present study, children and adolescents with isolated growth hormone deficiency or panhypopituitarism had plasma IRG levels similar to normal in the fasting state, and the plasma TRG responses to arginine were also similar to those observed in the normal group. Thus, prolonged pituitary G H deficiency does not appear to influence glucagon secretory responses, whereas insulin secretion may be clearly depressed. In prolonged fasting (2, 32, 38) , plasma IRG has been shown to rise until the third day of fasting, and thereafter, to decrease to a level maintained at or slightly above postabsorptive levels (38) . In our cases of anorexia nervosa, still largely underweight, fasting plasma IRG was not increased, and IRG responses to arginine were normal or slightly augmented as reported previously in starvation (2) .
The present findings of fasting plasma IRG levels in the normal range, together with a blood glucose level significantly lower than normal in the groups with anorexia nervosa, isolated growth hormone deficiency, and panhypopituitarism suggest that the glucagon response to hypoglycemia may he relatively deficient in these conditions. However, plasma glucagon as well as blood sugar increments after arginine infusion were normal or slightly greater than normal. Therefore, whether the hypoglycemia associated with anorexia nervosa or with hypopituitarism may be attributed to deficient glucagon secretion, cannot be answered definitively from the present data.
SUMMARY
The effects of intravenous infusion of arginine (20 g/m2) on plasma immunoreactive GH, IRI, IRG, and blood glucose were examined in 10 normal children and adolescents, 18 with idi- ' Data are presented as in Table 2 . Plasma glucagon concentrations are expressed in picograms per milliliter. P < 0.005 versus preinfusion (mean of -30 and 0 min) plasma glucagon concentration. P < 0.02 versus preinfusion (mean of -30 and 0 min) plasma glucagon concentration.
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opathic short stature, 6 with isolated growth hormone deficiency, 8 with panhypopituitarism, and 6 with anorexia nervosa. In the group with idiopathic short stature, fasting, as well as postarginine infusion plasma GH, IRI, IRG, and blood glucose concentrations, were similar to the values in the normal group. Plasma GH response to arginine was essentially absent in the groups with isolated GH deficiency and panhypopituitarism, but intact in anorexia nervosa; however, in ail three groups fasting blood glucose concentrations were significantly diminished and plasma IRI responses to arginine were significantly decreased. Plasma IRG, both fasting and after arginine infusion, was not significantly different from normal in all of the groups studied.
